DNAH8 and plasma cell myeloma: In breast cancer, oxidized Hsp90 (with reduced SSG) is associated with a poor treatment response, while the SSG of GSTP at Cys411/420 counteracts bortezomib resistance in multiple myeloma by impairing ATPase binding and protein folding (97).